Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 493

Wave breaks $66m series B

The nucleic acid drug developer previously secured $18m in a series A round backed by contract research company SNBL in February 2015.

Aug 19, 2015

SynCardia to transplant itself to public markets

The Delta Electronics-backed company, which has developed an artificial heart for transplants, has filed for a $40m initial public offering on Nasdaq.

Aug 19, 2015

Evolve to grow with $9m series A

Existing investor Tate and Lyle returned to back Evolve BioSystems' latest round, which will fund pre-commercialisation activities for its probiotics products.

Aug 18, 2015

Helix forms around $100m of cash

Newly launched genomics company Helix has secured investment from founding partners including Illumina, and additional cash from strategic partner Mayo Clinic.

Aug 18, 2015

Rhythm Metabolic fattens up with $40m

Pfizer and Ipsen, both of which previously backed Rhythm Metabolic's parent company, contributed to the obesity treatment developer's series A round.

Aug 14, 2015

Cancer drug developer Ascentage raises $15.5m

Ascentage Pharma, a spin-out of oncology company Ascenta Therapeutics, received $3m in funding from biotechnology company 3SBio in February.

Aug 13, 2015

PokitDok pockets $34m

The healthcare IT technology developer's series B round follows a $4m round in 2013 backed by telecommunications company Rogers Communications.

Aug 13, 2015

Kothari takes over at SRI Ventures

Manish Kothari was previously a director of commercial ventures and licensing at the corporate venturing unit, after initially joining SRI in 2013.

Aug 12, 2015

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here